Cargando…
Early Covid-19 vaccination rollout: a commentary from England
Early, rapid, nationally orchestrated vaccine rollout has been a feature in the response to the global coronavirus pandemic in Israel and the UK, two countries with long established, universal socialised health care systems. Although there are many differences between England and Israel, the factors...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907783/ https://www.ncbi.nlm.nih.gov/pubmed/33637133 http://dx.doi.org/10.1186/s13584-021-00451-3 |
_version_ | 1783655567673262080 |
---|---|
author | Sim, Fiona |
author_facet | Sim, Fiona |
author_sort | Sim, Fiona |
collection | PubMed |
description | Early, rapid, nationally orchestrated vaccine rollout has been a feature in the response to the global coronavirus pandemic in Israel and the UK, two countries with long established, universal socialised health care systems. Although there are many differences between England and Israel, the factors influencing the early days of the rollout merit exploration and learning that could be of benefit to other countries as they grapple to plan their own Covid-19 vaccine programmes. This commentary considers aspects of the rollout in both countries, in response to the article by Rosen and colleagues that identified contributing and facilitating factors in Israel. Whilst vaccine procurement and authorisation has been on a UK basis, and many features of rollout have been similar throughout the UK, the details provided pertain to England. |
format | Online Article Text |
id | pubmed-7907783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79077832021-02-26 Early Covid-19 vaccination rollout: a commentary from England Sim, Fiona Isr J Health Policy Res Commentary Early, rapid, nationally orchestrated vaccine rollout has been a feature in the response to the global coronavirus pandemic in Israel and the UK, two countries with long established, universal socialised health care systems. Although there are many differences between England and Israel, the factors influencing the early days of the rollout merit exploration and learning that could be of benefit to other countries as they grapple to plan their own Covid-19 vaccine programmes. This commentary considers aspects of the rollout in both countries, in response to the article by Rosen and colleagues that identified contributing and facilitating factors in Israel. Whilst vaccine procurement and authorisation has been on a UK basis, and many features of rollout have been similar throughout the UK, the details provided pertain to England. BioMed Central 2021-02-26 /pmc/articles/PMC7907783/ /pubmed/33637133 http://dx.doi.org/10.1186/s13584-021-00451-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Sim, Fiona Early Covid-19 vaccination rollout: a commentary from England |
title | Early Covid-19 vaccination rollout: a commentary from England |
title_full | Early Covid-19 vaccination rollout: a commentary from England |
title_fullStr | Early Covid-19 vaccination rollout: a commentary from England |
title_full_unstemmed | Early Covid-19 vaccination rollout: a commentary from England |
title_short | Early Covid-19 vaccination rollout: a commentary from England |
title_sort | early covid-19 vaccination rollout: a commentary from england |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907783/ https://www.ncbi.nlm.nih.gov/pubmed/33637133 http://dx.doi.org/10.1186/s13584-021-00451-3 |
work_keys_str_mv | AT simfiona earlycovid19vaccinationrolloutacommentaryfromengland |